High Tower Advisors, LLC Adaptive Biotechnologies Corp Transaction History

High Tower Advisors, LLC

  • $84.5 Billion
  • Q3 2025

A detailed history of High Tower Advisors, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 13,648 shares of ADPT stock, worth $192,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,648
Previous 16,922 19.35%
Holding current value
$192,436
Previous $197,000 3.55%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
SELL
$10.24 - $14.96 $33,525 - $48,979
-3,274 Reduced 19.35%
13,648 $204,000
Q2 2025

Aug 11, 2025
BUY
$6.83 - $12.16 $1,632 - $2,906
239 Added 1.43%
16,922 $197,000
Q1 2025

May 12, 2025
SELL
$6.07 - $8.66 $151 - $216
-25 Reduced 0.15%
16,683 $123,000
Q4 2024

Feb 07, 2025
BUY
$4.37 - $6.78 $109 - $169
25 Added 0.15%
16,708 $100,000
Q2 2024

Aug 13, 2024
BUY
$2.34 - $3.96 $2,585 - $4,375
1,105 Added 7.09%
16,683 $60,000
Q1 2024

May 06, 2024
SELL
$2.88 - $4.8 $2,306 - $3,844
-801 Reduced 4.89%
15,578 $50,000
Q4 2023

Feb 12, 2024
BUY
$3.46 - $5.33 $2,771 - $4,269
801 Added 5.14%
16,379 $80,000
Q2 2023

Aug 14, 2023
SELL
$6.19 - $8.78 $40,854 - $57,947
-6,600 Reduced 29.76%
15,578 $104,000
Q1 2023

May 11, 2023
SELL
$7.8 - $10.11 $43,095 - $55,857
-5,525 Reduced 19.94%
22,178 $195,000
Q3 2022

Nov 09, 2022
SELL
$6.5 - $12.67 $734 - $1,431
-113 Reduced 0.41%
27,703 $197,000
Q2 2022

Aug 10, 2022
BUY
$6.4 - $14.73 $105,081 - $241,851
16,419 Added 144.06%
27,816 $226,000
Q1 2022

May 12, 2022
BUY
$10.12 - $28.9 $115,337 - $329,373
11,397 New
11,397 $160,000
Q4 2021

Feb 10, 2022
SELL
$25.17 - $36.85 $309,867 - $453,660
-12,311 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$30.02 - $39.87 $56,707 - $75,314
-1,889 Reduced 13.3%
12,311 $418,000
Q2 2021

Aug 06, 2021
SELL
$32.22 - $44.59 $47,363 - $65,547
-1,470 Reduced 9.38%
14,200 $580,000
Q1 2021

May 10, 2021
SELL
$37.26 - $67.74 $485,944 - $883,465
-13,042 Reduced 45.42%
15,670 $631,000
Q4 2020

Feb 10, 2021
BUY
$45.01 - $65.47 $360,620 - $524,545
8,012 Added 38.71%
28,712 $1.7 Million
Q3 2020

Nov 13, 2020
BUY
$35.79 - $48.81 $277,372 - $378,277
7,750 Added 59.85%
20,700 $1.01 Million
Q2 2020

Aug 10, 2020
SELL
$24.95 - $48.38 $355,537 - $689,415
-14,250 Reduced 52.39%
12,950 $627,000
Q1 2020

May 21, 2020
SELL
$16.96 - $34.16 $511,768 - $1.03 Million
-30,175 Reduced 52.59%
27,200 $756,000
Q4 2019

Feb 14, 2020
BUY
$24.56 - $32.8 $1.41 Million - $1.88 Million
57,375 New
57,375 $1.72 Million

Others Institutions Holding ADPT

# of Institutions
290
Shares Held
147M
Call Options Held
23.5K
Put Options Held
33.3K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $2.01B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email